Medtronic (MDT) Reports Q3 EPS of $1.04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Medtronic (MDT) PT Raised to $90 at Jefferies on 'Very Good' Q3
February 18, 2015 7:51 AM ESTJefferies analyst Raj Denhoy reiterated a Buy rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to $89.00 (from $83.00) following Q3 results.
Denhoy commented, "MDT posted a very good F3Q, highlighted by: strength in CRDM, where the US quadpole... More
Medtronic (MDT) PT Lifted to $90 at Piper Jaffray Post Q3
February 18, 2015 7:44 AM ESTPiper Jaffray analyst Brooks West reiterated an Overweight rating and boosted his price target on Medtronic, Inc. (NYSE: MDT) to $90.00 (from $83.00) following Q3 results.
West commented, "Medtronic reported F3Q15 results, the last before reporting as combined Medtronic/ Covidien, with revenues of $4.318B (+8%cc) easily beating... More
